Back
Dave Vs. NovoCure Industry Stock Comparison
Buy
76
DAVE
Dave
Last Price:
$81.93
Seasonality Move:
-3.93%
Sell
35
NVCR
NovoCure
Last Price:
$20.05
Seasonality Move:
21.25%
Sell
35
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAVE Stock Price Chart
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.67 | Sell |
Relative Strength Index (14 RSI): | 40.93 | Sell |
Chaikin Money Flow: | 91000 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (90.1 - 110.3) | Sell |
Bollinger Bands (100): | (60.08 - 104) | Buy |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.19 | Sell |
Relative Strength Index (14 RSI): | 44.94 | Sell |
Chaikin Money Flow: | -716191 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.64 - 22.86) | Sell |
Bollinger Bands (100): | (17.5 - 28.32) | Sell |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 89.02 | Sell |
20-day SMA: | 100.01 | Sell |
50-day SMA: | 95.43 | Sell |
200-day SMA: | 59.7 | Buy |
8-day EMA: | 88.74 | Sell |
20-day EMA: | 94.56 | Sell |
50-day EMA: | 93.18 | Sell |
200-day EMA: | 66.88 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.52 | Buy |
20-day SMA: | 20.72 | Sell |
50-day SMA: | 24.51 | Sell |
200-day SMA: | 20.81 | Sell |
8-day EMA: | 20.19 | Buy |
20-day EMA: | 21.01 | Sell |
50-day EMA: | 22.72 | Sell |
200-day EMA: | 21.9 | Sell |
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.83 per share, an increase next quarter of $0.09 per share, an increase this year of $1.90 per share, and an increase next year of $0.79 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, an increase next quarter of $0.12 per share, a decrease this year of $0.75 per share, and an increase next year of $0.04 per share.
Dave Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |